Antibodies raised against different extracellular loops of the melanocortin-3 receptor affect energy balance and autonomic function in rats

References

• Adan RA, Tiesjema B, Hillebrand JJ, la Fleur SE, Kas MJ, de Krom M. The MC4 receptor and control of appetite. Br J Pharmacol 2006, 149, 815–827.
   PubMed Web of Science ®Google Scholar
• Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005, 8, 571–578.
   PubMed Web of Science ®Google Scholar
• Nordheim U, Nicholson JR, Dokladny K, Dunant P, Hofbauer KG. Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive rats. Peptides 2006, 27, 438–443.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Schwartz MW. Melanocortins and body weight: a tale of two receptors. Nat Genet 2000, 26, 8–9.
   PubMed Web of Science ®Google Scholar
• Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 1993, 90, 8856–8860.
   PubMed Web of Science ®Google Scholar
• Cowley MA, Smart JL, Rubinstein M, Cerdán MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 411, 480–484.
   PubMed Web of Science ®Google Scholar
• Lee M, Kim A, Conwell IM, Hruby V, Mayorov A, Cai M, Wardlaw SL. Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression. Peptides 2008, 29, 440–447.
   PubMed Web of Science ®Google Scholar
• Marks DL, Hruby V, Brookhart G, Cone RD. The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides 2006, 27, 259–264.
   PubMed Web of Science ®Google Scholar
• Peter JC, Nicholson JR, Heydet D, Lecourt AC, Hoebeke J, Hofbauer KG. Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 2007, 292, R2151–R2158.
   PubMed Web of Science ®Google Scholar
• Butler AA. The melanocortin system and energy balance. Peptides 2006, 27, 281–290.
   PubMed Web of Science ®Google Scholar
• Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000, 26, 97–102.
   PubMed Web of Science ®Google Scholar
• Neimark J, Briand JP. Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Pept Res 1993, 6, 219–228.
   PubMedGoogle Scholar
• Kramer K, Kinter LB. Evaluation and applications of radiotelemetry in small laboratory animals. Physiol Genomics 2003, 13, 197–205.
   PubMed Web of Science ®Google Scholar
• Kamel R, Garcia S, Lezoualc’h F, Fischmeister R, Muller S, Hoebek J, Eftekhari P. Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT4 receptor and its consequences in early BALB/c mouse embryonic development. BMC Dev Biol 2007, 7, 34.
   PubMed Web of Science ®Google Scholar
• Escobar AL, Fernández-Gómez R, Peter JC, Mobini R, Hoebeke J, Mijares A. IgGs and Mabs against the beta2-adrenoreceptor block A-V conduction in mouse hearts: a possible role in the pathogenesis of ventricular arrhythmias. J Mol Cell Cardiol 2006, 40, 829–837.
   PubMed Web of Science ®Google Scholar
• Peter JC, Tugler J, Eftekhari P, Maurice D, Hoebeke J, Roegel JC. Effects on heart rate of an anti-M2 acetylcholine receptor immune response in mice. FASEB J 2005, 19, 943–949.
   PubMed Web of Science ®Google Scholar
• Hao X, Li S, Liu H, Wu B. Immunization with beta(1)-adrenoreceptor peptide induces cardiomyopathy-like changes in rabbit hearts. Chin Med J 2002, 115, 170–174.
   PubMed Web of Science ®Google Scholar
• Kamel R, Eftekhari P, Clancy R, Buyon JP, Hoebeke J. Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: a reassessment. J Autoimmun 2005, 25, 72–76.
   PubMed Web of Science ®Google Scholar
• Lebesgue D, Wallukat G, Mijares A, Granier C, Argibay J, Hoebeke J. An agonist-like monoclonal antibody against the human beta2-adrenoceptor. Eur J Pharmacol 1998, 348, 123–133.
   PubMed Web of Science ®Google Scholar
• Peter JC, Eftekhari P, Billiald P, Wallukat G, Hoebeke J. scFv single chain antibody variable fragment as inverse agonist of the beta2-adrenergic receptor. J Biol Chem 2003, 278, 36740–36747.
   PubMed Web of Science ®Google Scholar
• Peter JC, Wallukat G, Tugler J, Maurice D, Roegel JC, Briand JP, Hoebeke J. Modulation of the M2 muscarinic acetylcholine receptor activity with monoclonal anti-M2 receptor antibody fragments. J Biol Chem 2004, 279, 55697–55706.
   PubMed Web of Science ®Google Scholar
• Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993, 268, 15174–15179.
   PubMed Web of Science ®Google Scholar
• Kenakin T. New concepts in drug discovery: collateral efficacy and permissive antagonism. Nat Rev Drug Discov 2005, 4, 919–927.
   PubMed Web of Science ®Google Scholar
• Keov P, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. Neuropharmacology 2010, In press.
   Google Scholar
• Guillet JG, Lengagne R, Magnusson Y, Tate K, Strosberg AD, Hoebeke J. Induction of a pharmacologically active clonotypic B cell response directed to an immunogenic region of the human beta 2-adrenergic receptor. Clin Exp Immunol 1992, 89, 461–467.
   PubMed Web of Science ®Google Scholar
• Wallukat G, Wollenberger A. Autoantibodies to beta 2-adrenergic receptors with antiadrenergic activity from patients with allergic asthma. J Allergy Clin Immunol 1991, 88, 581–587.
   PubMed Web of Science ®Google Scholar
• Kamel R, Eftekhari P, Garcia S, Berthouze M, Berque-Bestel I, Peter JC, Lezoualc’h F, Hoebeke J. A high-affinity monoclonal antibody with functional activity against the 5-hydroxytryptaminergic (5-HT4) receptor. Biochem Pharmacol 2005, 70, 1009–1018.
   PubMed Web of Science ®Google Scholar
• Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88, 131–141.
   PubMed Web of Science ®Google Scholar
• Feng N, Young SF, Aguilera G, Puricelli E, Adler-Wailes DC, Sebring NG, Yanovski JA. Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 2005, 54, 2663–2667.
   PubMed Web of Science ®Google Scholar
• Ni XP, Butler AA, Cone RD, Humphreys MH. Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones. J Hypertens 2006, 24, 2239–2246.
   PubMed Web of Science ®Google Scholar
• Kawabe T, Chitravanshi VC, Kawabe K, Sapru HN. Cardiovascular effects of adrenocorticotropin microinjections into the rostral ventrolateral medullary pressor area of the rat. Brain Res 2006, 1102, 117–126.
   PubMed Web of Science ®Google Scholar
• Ni XP, Pearce D, Butler AA, Cone RD, Humphreys MH. Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. J Clin Invest 2003, 111, 1251–1258.
   PubMed Web of Science ®Google Scholar
• Sutton GM, Trevaskis JL, Hulver MW, McMillan RP, Markward NJ, Babin MJ, Meyer EA, Butler AA. Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 2006, 147, 2183–2196.
   PubMed Web of Science ®Google Scholar
• Hofbauer KG, Lecourt AC, Peter JC. Antibodies as pharmacologic tools for studies on the regulation of energy balance. Nutrition 2008, 24, 791–797.
   PubMed Web of Science ®Google Scholar
• Marks DL, Cone RD. The role of the melanocortin-3 receptor in cachexia. Ann N Y Acad Sci 2003, 994, 258–266.
   PubMed Web of Science ®Google Scholar
• Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000, 141, 3518–3521.
   PubMed Web of Science ®Google Scholar
• Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O’Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003, 348, 1085–1095.
   PubMed Web of Science ®Google Scholar